Powered by Max Banner Ads  

Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.

Nov 1, 2009

Related Articles

Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.

Clin Ther. 2009 Sep;31(9):1992-2001

Authors: Sp

Share with others

No Responses so far | Have Your Say!

Leave a Feedback

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Click Here!



 Powered by Max Banner Ads